Trial shows a faster approach for starting extended-release naltrexone to treat opioid use disorder is effective

Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more effective than the standard treatment method of starting within 10–15 days, but requires closer medical supervision, according to results from a clinical trial published in JAMA Network Open.

​Medical Xpress – latest medical and health news stories

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *